BOUNDLESS BIO, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BOUNDLESS BIO, INC. (BOLD) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.95 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- BOUNDLESS BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 5.94M shares, a 25.33% increase year-over-year.
- BOUNDLESS BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 4.74M shares, a 24952.88% increase year-over-year.
- BOUNDLESS BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 18.91K shares, a 99.89% decline year-over-year.
- BOUNDLESS BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 17.56M shares.
- BOUNDLESS BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 3.82K shares, a 78.25% decline from fiscal 2023.
- BOUNDLESS BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 17.56K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.95M shares 10-Q · filed 2026-08-07 | ||||||
| 2026-03-31 | 5.94M shares 10-Q · filed 2026-05-08 | ||||||
| 2025-09-30 | 4.37K shares 10-Q · filed 2025-11-05 | ||||||
| 2025-06-30 | 4.65M shares 10-Q · filed 2026-08-07 | 4.65K shares 10-Q · filed 2025-08-05 | |||||
| 2025-03-31 | 4.74M shares 10-Q · filed 2026-05-08 | 4.74K shares 10-Q · filed 2025-05-09 | |||||
| 2024-12-31 | 3.82K shares 10-K · filed 2025-03-27 | ||||||
| 2024-09-30 | 4.24K shares 10-Q · filed 2025-11-05 | 4.24M shares 10-Q · filed 2024-11-07 | |||||
| 2024-06-30 | 4.19K shares 10-Q · filed 2025-08-05 | 4.19M shares 10-Q · filed 2024-08-12 | |||||
| 2024-03-31 | 18.91K shares 10-Q · filed 2025-05-09 | 18.91M shares 10-Q · filed 2024-05-13 | |||||
| 2023-12-31 | 17.56K shares 10-K · filed 2025-03-27 | ||||||
| 2023-09-30 | 17.43M shares 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | 17.21M shares 10-Q · filed 2024-08-12 | ||||||
| 2023-03-31 | 17.56M shares 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |